ClinVar Miner

Submissions for variant NM_000161.3(GCH1):c.644T>C (p.Met215Thr)

dbSNP: rs2140038918
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India RCV002264873 SCV002546240 likely pathogenic GTP cyclohydrolase I deficiency with hyperphenylalaninemia criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV002264873 SCV005044819 uncertain significance GTP cyclohydrolase I deficiency with hyperphenylalaninemia criteria provided, single submitter clinical testing The missense c.644T>C p.Met215Thr variant in GCH1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Met215Thr variant is novel not in any individuals in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic. The amino acid change p.Met215Thr in GCH1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Met at position 215 is changed to a Thr changing protein sequence and it might alter its composition and physico-chemical properties. Functional studies are required to prove the pathogenicity for the variant, for these reasons, this variant has been classified as Variant of Uncertain Significance VUS.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.